AI-generated summary
The authors report an attempt to improve radiotherapy for locally advanced skin cancer by adding radiosensitizers: the drug metronidazole, applied locally through a textile drug applicator, and low-intensity laser emission. They state that this combination was associated with significantly better immediate treatment results without a rise in local radiation reactions. The abstract does not report a sample size or a control group, and it provides limited detail on recurrence.
- Who or what was studied
- Patients with locally advanced skin cancer (T2 basal cell and squamous cell carcinomas, tumors 4-5 cm, and T3 tumors)
- Limits stated in the abstract
- The abstract gives no participant count, no comparison group, and little detail on recurrence rates or follow-up.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on pubmed.ncbi.nlm.nih.gov.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Laser, Dose. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.